FDA NDC Directory · JSON-LD · Markdown

Exosomes

NDC 88051-002 · DRUG FOR FURTHER PROCESSING · LIQUID

Labeler / ManufacturerRegenerative Cell Research Institute Private Ltd.
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeLIQUID
Active ingredientsALLOGENIC HUMAN PLACENTAL MESENCHYMAL STEM CELL-DERIVED EXOSOMES (1 kg/L)
Marketing started20261016
Package count3

External sources

Source: openFDA. Public-domain (CC0).